Journal Information
Editorial
New strategies for decision making in prostate cancer. The role of oncotypedx
C. Toribio-Vázquez, J. Gómez Rivas, Á. Yebes, D.M. Carrión, M. Yagüe Barrado, M. Álvarez-Maestro, L. Martinez-Piñeiro
Actas Urol Esp. 2022;46:385-6
Review article
Systematic review on active treatment for urinary fistula after partial nephrectomy
R. Massouh Skorin, A. Mahfouz, P. Escovar la Riva
Actas Urol Esp. 2022;46:387-96
Original articles
The role of multiparametric mri in the diagnosis of local recurrence after radical prostatectomy and before salvage radiotherapy
E. Faiella, D. Santucci, D. Vertulli, F. Esperto, L. Messina, G. Castiello, R. Papalia, G. Flammia, ... B. Beomonte Zobel
Actas Urol Esp. 2022;46:397-406
Hounsfield units: A promising non-invasive tool for diagnosing benign prostatic hyperplasia
O. Yilmaz, H. Hayit, C. Yesildal, S. Yenigurbuz, F. Yilmaz, Y. Emre Kizilkan
Actas Urol Esp. 2022;46:407-12
Prognostic significance of age, sex, race, and socioeconomic status in patients with stage III–IV upper tract urothelial carcinoma
Z. Zhou, H.J. Shi, L. Jin, X. Liu, T.S. Zhai, J.X. Zhang, L. Ye
Actas Urol Esp. 2022;46:413-22
The probability of residual tumor detection in the second transurethral resection of pT1 urothelial bladder cancer according to the risk factors
M. Culpan, O. Kazan, H. Cansu Acar, A. Iplikci, G. Atis, A. Yildirim
Actas Urol Esp. 2022;46:423-30
Impact of a radical prostatectomy on the urodynamic results of prostate cancer patients treated with intensity modulated radiation therapy
J. Casas-Nebra, B. Blanco-Gomez, A. Medina-González, I. Formoso-Garcia, S. Escaf-Barmadah, A. Alvarez-Arenal
Actas Urol Esp. 2022;46:431-41
Phytotherapy for male luts: What happens then? 10-year research
L.G. Luciani, D. Mattevi, V. Vattovani, T. Cai, G. Giusti, G. Malossini
Actas Urol Esp. 2022;46:442-6